| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.3 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |